Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PRAVASTATIN Cause Chronic obstructive pulmonary disease? 35 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Chronic obstructive pulmonary disease have been filed in association with PRAVASTATIN (Pravastatin Sodium). This represents 0.4% of all adverse event reports for PRAVASTATIN.

35
Reports of Chronic obstructive pulmonary disease with PRAVASTATIN
0.4%
of all PRAVASTATIN reports
0
Deaths
27
Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From PRAVASTATIN?

Of the 35 reports, 27 (77.1%) required hospitalization.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PRAVASTATIN. However, 35 reports have been filed with the FAERS database.

What Other Side Effects Does PRAVASTATIN Cause?

Myalgia (1,290) Arthralgia (570) Dyspnoea (514) Fatigue (500) Drug hypersensitivity (493) Diarrhoea (478) Headache (448) Pruritus (432) Nausea (420) Dizziness (413)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which PRAVASTATIN Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

PRAVASTATIN vs PRAVASTATIN\PRAVASTATIN PRAVASTATIN vs PRAZAXA PRAVASTATIN vs PRAZEPAM PRAVASTATIN vs PRAZIQUANTEL PRAVASTATIN vs PRAZOSIN

Related Pages

PRAVASTATIN Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease PRAVASTATIN Demographics